Form 8-K - Current report:
SEC Accession No. 0000950170-24-120902
Filing Date
2024-11-04
Accepted
2024-11-04 17:09:40
Documents
12
Period of Report
2024-11-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-20241104.htm   iXBRL 8-K 63617
2 EX-99.1 hrtx-ex99_1.htm EX-99.1 8493
  Complete submission text file 0000950170-24-120902.txt   197176

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hrtx-20241104.xsd EX-101.SCH 30706
14 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20241104_htm.xml XML 4715
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 241424633
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)